Improving poultry vaccine supply: Inside the manufacturing process

Behind every successful poultry operation is a dependable vaccine supply chain. But producing vaccines is no small feat — it requires precision, foresight and the ability to adapt to biological and regulatory challenges. Daniel Hamby, senior associate director of manufacturing science and technology at Boehringer Ingelheim, gives a behind-the-scenes look at vaccine production and explains what it takes to deliver consistent, high-quality products to the industry.

How data-driven insights are reshaping flock management

Data is playing a growing role in helping producers manage risk, optimize health and justify production decisions. From digitizing information to store it securely to using it to guide real-time decision-making, for Dan Wilson, DVM, founder of Wilson Veterinary Co., it has become integral to the way he works with producers to improve flock performance.

Import license for avian metapneumovirus vaccine offers new tool for producers

Faced with the emerging disease threat posed by avian metapneumovirus (aMPV), the USDA is allowing the importation of three vaccines from Boehringer Ingelheim: the live virus products NEMOVAC™ for use in chickens and AVIFFA RTI for use in turkeys and chickens, as well as the TUR-3 inactivated vaccine for primary vaccination of both turkey and chicken flocks against aMPV subtype B.

Interview: Optimizing vaccine performance in the field

Vaccines are essential tools for managing diseases in poultry and ensuring flock welfare. Taking shortcuts with them is never a good idea, however, and there’s plenty of research to prove it. In the second of a two-part series, Bill Stanley, DVM, and Isabel Gimeno, DVM, PhD, talked about their experiences managing vaccines and ensuring optimum performance.